结核性脊柱炎:BCG病罕见并发症在18F-PSMA-1007 PET/CT上伪装为转移灶
本文报道一例膀胱癌膀胱内BCG免疫治疗后继发BCG病(BCGosis)的患者,在18F-PSMA PET/CT评估前列腺癌时偶然发现椎体病灶异常摄取,后证实为椎体骨炎,很可能由BCG免疫治疗所致。病例强调多学科评估对确认18F-PSMA PET/CT异常摄取灶性质的作用。
要点
- BCG病是膀胱内BCG免疫治疗的罕见并发症,可表现为播散性结核或器官特异性结核,累及椎体罕见。
- PSMA在前列腺癌中过表达,但也可在多种良恶性病变中表达,18F-PSMA PET/CT异常椎体摄取需鉴别。
- 本病例椎体病灶经证实为骨炎,很可能由BCG免疫治疗所致,而非转移。
核心结论
- BCG病可表现为椎体骨炎,在18F-PSMA PET/CT上可被误认为转移灶。
- 病例强调多学科评估对确认18F-PSMA PET/CT异常病灶性质的作用。
研究设计与样本
- 病例报告:一例接受膀胱内BCG免疫治疗作为膀胱癌辅助治疗的患者,在前列腺癌18F-PSMA PET/CT评估中偶然发现椎体病灶异常摄取。
主要发现
- 18F-PSMA PET/CT偶然发现椎体病灶异常摄取。
- 该椎体病灶随后证实为椎体骨炎,很可能由BCG免疫治疗所致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BCGosis is a rare complication of intravesical BCG immunotherapy as adjuvant therapy for urinary bladder cancer manifesting in the form of disseminated tuberculosis or organ-specific tuberculosis, rarely involving the vertebra. PSMA is overexpressed in prostate cancer but also expressed in a variety of benign and malignant conditions. We present a patient with incidental detection of abnormal uptake in a vertebral lesion during assessment of prostate cancer with 18F-PSMA PET/CT, subsequently proven to be vertebral osteitis, likely due to BCG immunotherapy. The case highlights the role of interdisciplinary patient assessment to confirm nature of abnormal foci on 18F-PSMA PET/CT.
引用
- Bohil A, Seshadri N, Rathi N, et al. Tubercular Spondylitis: A Rare Complication of BCGosis Masquerading as Metastasis on 18F-PSMA-1007 PET/CT. Clin Nucl Med. 2022. PMID: 35020662. doi:10.1097/RLU.0000000000003989
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。